StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.
Company profile
Ticker
SZLSF
Exchange
Website
CEO
James R. Howard-Tripp
Employees
Incorporated
Location
Fiscal year end
Former names
GENENEWS LTD
SEC CIK
SZLSF stock data
Latest filings (excl ownership)
D
$3.22M in equity / options / securities to be acquired, sold $1.48M, 1 investor
17 Mar 22
D/A
$7.4M in equity / options / securities to be acquired, sold $3.29M, 6 investors
7 Feb 22
D
$7.4M in equity / options / securities to be acquired, sold $3.29M, 6 investors
4 Jan 22
D
$338.14K in equity / options / securities to be acquired, sold $198.31K, 1 investor
18 Dec 20
D
$113.45K in equity / options / securities to be acquired, sold $113.37K, 1 investor
23 Jun 20
D
$2.54M in equity / debt / options / securities to be acquired, sold $1.54M, 1 investor
22 Jun 18
D
$1.58M in equity / options / securities to be acquired, sold $852.22K, 3 investors
6 Jun 18
D
$245.56K in equity, sold $245.56K, 3 investors
31 Jul 17
D
Indefinite amount in equity, sold $370.44K, 3 investors
14 Apr 16
D
$7.21M in equity, sold $5.97M, 8 investors
22 Jul 14
Latest ownership filings
No filings
Institutional ownership, Q4 2020
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.00 k |
Total shares | 10.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Front Row Advisors | 10.00 k | $6.00 k |
Press releases
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order
9 Jul 24
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order
3 Jul 24
StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
23 May 24
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
17 May 24